Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant risks » significant risk (Expand Search), significant results (Expand Search), significant role (Expand Search)
risks decrease » sizes decrease (Expand Search), visits decreased (Expand Search), rivers decreased (Expand Search)
Showing 461 - 480 results of 3,614 for search '(( significant risks decrease ) OR ( significant decrease decrease ))~', query time: 0.22s Refine Results
  1. 461
    Absolute and relative atrial fibrillation and flutter DALYs rate attributable to 2<sup>nd</sup> level risk factors in Chile.

    Absolute and relative atrial fibrillation and flutter DALYs rate attributable to 2<sup>nd</sup> level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 462
    Absolute and relative hypertensive heart disease DALYs rate attributable to 2<sup>nd</sup> level risk factors in Chile.

    Absolute and relative hypertensive heart disease DALYs rate attributable to 2<sup>nd</sup> level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 463
    Proportion of stillbirths in Stockholm among twin and singleton pregnancies.

    Proportion of stillbirths in Stockholm among twin and singleton pregnancies. by Matilda Varli Hjärne (22766125)

    Published 2025
    Save to List
    Saved in:
  4. 464
    Grade system.

    Grade system. by Zhuoyang Xia (21354186)

    Published 2025
    “…The DerSimonian–Laird random-effects model and the Cochrane Collaboration’s risk of Bias Tool were used for analysis and risk of bias assessment.…”
    Save to List
    Saved in:
  5. 465
    Literature search.

    Literature search. by Zhuoyang Xia (21354186)

    Published 2025
    “…The DerSimonian–Laird random-effects model and the Cochrane Collaboration’s risk of Bias Tool were used for analysis and risk of bias assessment.…”
    Save to List
    Saved in:
  6. 466
    Study characteristics.

    Study characteristics. by Zhuoyang Xia (21354186)

    Published 2025
    “…The DerSimonian–Laird random-effects model and the Cochrane Collaboration’s risk of Bias Tool were used for analysis and risk of bias assessment.…”
    Save to List
    Saved in:
  7. 467
    Flowchart of literature retrieval.

    Flowchart of literature retrieval. by Zhuoyang Xia (21354186)

    Published 2025
    “…The DerSimonian–Laird random-effects model and the Cochrane Collaboration’s risk of Bias Tool were used for analysis and risk of bias assessment.…”
    Save to List
    Saved in:
  8. 468
    Data extraction.

    Data extraction. by Zhuoyang Xia (21354186)

    Published 2025
    “…The DerSimonian–Laird random-effects model and the Cochrane Collaboration’s risk of Bias Tool were used for analysis and risk of bias assessment.…”
    Save to List
    Saved in:
  9. 469
    Socio-demographic and medical characteristics of patients with liver cancer.

    Socio-demographic and medical characteristics of patients with liver cancer. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 470
    Data cleaning and preparation algorithm.

    Data cleaning and preparation algorithm. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 471
    Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023.

    Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 472
    Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023.

    Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 473
    Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific.

    Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 474
    Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023.

    Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 475
    Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023.

    Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 476
    Crude and age-specific mortality to incidence ratios of liver cancer per 100,000 over 2014–2023.

    Crude and age-specific mortality to incidence ratios of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 477
    Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023.

    Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 478
    Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023.

    Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 479
    Regional and temporal burden of liver cancer in Kazakhstan (2014–2023).

    Regional and temporal burden of liver cancer in Kazakhstan (2014–2023). by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 480
    FPRP values for the association between rs12529 and breast cancer risk.

    FPRP values for the association between rs12529 and breast cancer risk. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Save to List
    Saved in:

Search Tools: